Factors affecting the development of adverse drug reactions (Review article)
about
The effects of microRNA on the absorption, distribution, metabolism and excretion of drugsCost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in GermanyXenobiotic Metabolism and Gut MicrobiomesIncidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatientsAdverse drug reactions in hospitalized Colombian children.Adverse drug events-Analysis of a decade. A Portuguese case-study, from 2004 to 2013 using hospital database.Factors predictive of treatment-emergent adverse events of prucalopride: an integrated analysis of four randomized, double-blind, placebo-controlled trials.Comparative study on drug safety surveillance between medical students of Malaysia and NigeriaGender-based personalized pharmacotherapy: a systematic review.Three week dietary intervention using apricots, pomegranate juice or/and fermented sour sobya and impact on biomarkers of antioxidative activity, oxidative stress and erythrocytic glutathione transferase activity among adultsMonitoring of adverse drug reactions in psychiatry outpatient department of a Secondary Care Hospital of Ras Al Khaimah, UAE.Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative reviewAdverse Reactions to Radioiodine 131I Therapy of Goiter in West African Tertiary HospitalExpression profiling and functional annotation of noncoding genes across 11 distinct organs in rat development.Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy.Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia.Impact of comorbidity on adverse drug reaction profile in a cohort of patients treated with Artemisinin combination therapies for uncomplicated malaria in Nigeria.Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.Risk factors for adverse drug reactions in pediatric inpatients: A cohort study.Quantum mechanics implementation in drug-design workflows: does it really help?Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients.Adverse Drug Reaction Monitoring in a Tertiary Care Psychiatry Setting: A Comparative Study between Inpatients and Outpatients.Surveillance study on the tolerability and safety of Flebogamma® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients.Serum lipid and glucose profiles in HIV-positive Nigerian children.A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College.Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.Categorization and association analysis of risk factors for adverse drug events.Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?Role of physical exercise and omega-3 fatty acids on depressive illness in the elderly.Comparative study of hemodynamic changes caused by diazepam and midazolam during third molar surgery: a randomized controlled trial.Pharmacovigilance in developing countries (part I): importance and challenges.YiQiFuMai injection for chronic heart failure: Protocol for a systematic review and meta-analysis.Comparison of online reporting systems and their compatibility check with respective adverse drug reaction reporting forms.Evaluation of Supportive Care Management Outcomes in Cancer Chemotherapy: A Prospective Observational Study in a Tertiary Care Teaching Hospital in South India.An analysis of adverse drug reactions in extremes of age group at tertiary care teaching hospital.Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection.Retrospective Study of Reported Adverse Events Due to Complementary Health Products in Singapore From 2010 to 2016.Causality and preventability assessment of adverse drug events of antibiotics among inpatients having different lengths of hospital stay: a multicenter, cross-sectional study in Lahore, Pakistan.Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.Investigating Organ Toxicity Profile of Tenofovir and Tenofovir Nanoparticle on the Liver and Kidney: Experimental Animal Study
P2860
Q26822987-63BC31B5-207B-44F5-8CE8-5B96B4EFBFF9Q28072203-39A46F4D-5F10-4208-9AB9-01D09457F2E7Q28554445-EA194C4B-6263-4E3A-8FBF-DC54ADE0F0C2Q28559384-68BC5E01-ACEA-4589-8DC6-3F337EA8715BQ30380639-8CD34333-C62D-4DC6-8559-4B637C5E498CQ33757595-1FD8F9FE-4C22-439D-9B03-1DE3489B6CD6Q35151791-835106C9-A106-4E2A-B1AE-BA0EF2B7EFABQ35821943-4CFE7B2D-1ED8-4DF8-8853-D09E9466D1D5Q36335289-831BFB50-B0BA-4484-A14F-49B995429ECFQ36895412-FC669B57-7D16-4D71-840F-536E7DFB421CQ37011680-254D72A8-389D-4510-977B-4AFB019E1615Q37242205-6705AD75-5B1A-43FA-A306-4DA43CB44189Q37400468-2227A92A-995A-4DB6-AAC8-2E737B2B955BQ37488122-70152AD8-C0AA-4A7D-AF15-6122C8F229EAQ37512208-1EDA7497-6F58-4A80-9FA2-A0C10BED7602Q37634673-5CD02CB0-17ED-459C-A895-1BAD39B18EBAQ37724300-80D57BFF-B88A-49C3-8E47-5ACFD60DF68DQ40144352-3910E418-AD7E-4B2C-B783-12AC4701FE25Q41200319-D0D58FAC-6F4B-48D3-8ABA-D3663ED28A1CQ41633463-75D9345A-C6DA-4162-813C-FCE22B8945ABQ41893748-1F90F2E6-F53F-440D-9EDA-020E4BAB2137Q42093758-13E688F7-4BA8-4C97-88B5-85D5D5E56242Q42183204-38C6ECE0-141F-472B-ADAD-E98C221EE44CQ42334793-65D6BCF2-B83F-4BAF-99B0-784568F4CCEBQ47106036-177654F4-6BE9-45B2-8215-D6C38571CFEEQ47156616-84AE953D-A3C8-445A-9A5D-22F61D56DAE2Q47339342-E188E6F8-4992-40C7-A37A-33342696BACCQ47450129-56B24D9F-07E1-4CBB-BBB9-0EF75FB5D109Q47623310-A7692700-94E8-4505-ACBB-6D0429AE0F0EQ47740766-E7B47845-3C82-4639-9D90-DB3B07F99B98Q48105245-A35E0F2D-01C3-4A16-B647-57466EB6110EQ49711980-2BA32B70-A007-4001-B4BC-79C1A3478F7EQ52668500-1841F9A6-8394-4D6D-8696-A3C92E6076C9Q55011188-083FD8A3-4D29-4CC7-B64D-DE646BA06909Q55228545-E4A8C252-AD30-4ED7-8260-F04725378127Q55407610-7618C1D2-B002-4EF4-B866-A5262864FCE4Q55427610-D8721434-C002-464F-9DB1-1C5716601EF1Q55428132-670DCF04-C397-4DB1-90C8-4D8DAD099014Q55513301-C4AEDA52-650D-487A-A469-3C92C7122B55Q56965337-1B349F49-E7E3-497E-864E-7D6E5DA9FC9D
P2860
Factors affecting the development of adverse drug reactions (Review article)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factors affecting the development of adverse drug reactions (Review article)
@en
Factors affecting the development of adverse drug reactions
@nl
type
label
Factors affecting the development of adverse drug reactions (Review article)
@en
Factors affecting the development of adverse drug reactions
@nl
prefLabel
Factors affecting the development of adverse drug reactions (Review article)
@en
Factors affecting the development of adverse drug reactions
@nl
P2860
P1476
Factors affecting the development of adverse drug reactions (Review article)
@en
P2093
Muaed Jamal Alomar
P2860
P356
10.1016/J.JSPS.2013.02.003
P577
2013-02-24T00:00:00Z